⌘K

Home/Filings/4/0001493152-23-000409

4//SEC Filing

Dubin Michael F 4

Accession 0001493152-23-000409

CIK 0001708331other

View on SEC.gov Company Profile

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 8:30 PM ET

Size

5.1 KB

Accession

0001493152-23-000409

Insider Transaction Report

Form 4

Period: 2023-01-01

Virpax Pharmaceuticals, Inc.VRPX

Dubin Michael F

Director

Transactions

Award
Stock Option (right to buy)
2023-01-01+20,000→ 20,000 total
Exercise: $0.62From: 2024-01-01Exp: 2033-01-01→ Common Stock (20,000 underlying)

Documents

1 file

4
ownership.xmlPrimary

Issuer

Virpax Pharmaceuticals, Inc.

CIK 0001708331

Entity typeother

Related Parties

1

filerCIK 0001876497

Filing Metadata

Form type: 4
Filed: Jan 3, 7:00 PM ET
Accepted: Jan 4, 8:30 PM ET
Size: 5.1 KB

View on SEC.gov